BLACK FRIDAY20% OFF EVERYTHINGSAME-DAY EU DISPATCHENDS 30 NOVEMBER

BPC-157 vs TB-500: Structure, Pathways and Research Differences

Lab guide · Comparisons

BPC-157 vs TB-500: Structure, Pathways and Research Differences

BPC-157 vs TB-500 compares two unrelated peptides that are often mentioned together: a 15-residue peptide described as part of a gastric-juice protein, and thymosin beta-4, a 43-residue actin-binding protein (sold under the TB-500 name). This guide sets out the seven differences that matter, what the evidence for each looks like and why the two should not be treated as interchangeable.

Baltic Peptides lab team9 min readUpdated 22 November 2026

FAQ

Common questions

What is the difference between BPC-157 and TB-500?
They are unrelated molecules. BPC-157 is a 15-residue peptide described as part of a gastric-juice protein, while TB-500, as supplied by Baltic Peptides, is 43-residue thymosin beta-4, an actin-binding protein.
How do the molecular weights of BPC-157 and TB-500 compare?
BPC-157 is about 1419.5 g/mol and thymosin beta-4 is about 4963.5 g/mol, so intact-mass testing separates them easily.
Do BPC-157 and TB-500 work the same way?
No. In research, BPC-157 has been linked to VEGFR2-Akt-eNOS signalling in endothelial cell studies, while thymosin beta-4 binds G-actin in a 1:1 complex and has ILK-Akt signalling reported in cardiac cells.
Are BPC-157 and TB-500 studied in the same models?
They overlap in some preclinical injury and vessel models, but BPC-157 is studied more in tendon and gastrointestinal models and thymosin beta-4 more in dermal, corneal and cardiac models.
Is TB-500 the same as thymosin beta-4?
Often, but not always. TB-500 is also used for a seven-residue fragment, Ac-LKKTETQ, so the molecule should be confirmed by mass.
Is there human evidence for either compound?
Very little for BPC-157, which has one retrospective report in 12 patients and no human safety data. Trials of full-length thymosin beta-4 have been run or proposed, but none has led to approval.
Is a BPC-157 and TB-500 blend the same as using each separately?
No evidence shows that. A blend is a physical mixture, and how the two interact has to be measured against single-compound controls.

Keep reading

Related reading

What is BPC-157?

Structure, history and the evidence behind BPC-157.

What is TB-500?

Thymosin beta-4 and the TB-500 naming problem.

Peptide blends explained

Why component research does not define a mixture.

Research-grade BPC-157 and TB-500, tested before they ship

Independent HPLC and mass spec results for every batch, dispatched from the EU.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
0